INVESTOR PRESENTATION May 2025 Forward-looking statements involve known and unknown risks and uncertainties that may cause future results to differ materially from those suggested by the forward-looking statements. Such risks and uncertainties include, but are not limited to the following; our business, operations, customers, suppliers nd employees; general economic conditions in the areas of the United States in which the Company's customers are located; changes in the market where uniforms are worn, where ...

Guild Company (GHLD) Q1 2025 Earnings Call May 07, 2025 05:00 PM ET Company Participants None - ExecutiveTerry Schmidt - CEO & DirectorDavid Neylan - President & COOAmber Kramer - SVP & CFODonald Fandetti - Managing DirectorMikhail Goberman - VP - Equity Research Conference Call Participants Richard Shane - AnalystJake Katsikas - Equity Research Analyst Operator Good afternoon, ladies and gentlemen, and welcome to the Guild Holdings Company First Quarter twenty twenty five Earnings Conference Call. At this ...

Voya Financial (VOYA) Q1 2025 Earnings Call May 07, 2025 10:00 AM ET Speaker0 Good morning. Welcome to Voya Financial's First Quarter twenty twenty five Earnings Conference Call. All participants will be in a listen only mode. Please note this event is being recorded. I would now like to turn the call over to May Nie Chew, Head of Investor Relations. Please go ahead. Speaker1 Good morning and thank you for joining us for Voya Financial's first quarter twenty twenty five earnings conference call. As a remind ...

Core Insights - Techne (TECH) reported revenue of $316.18 million for the quarter ended March 2025, reflecting a year-over-year increase of 4.2% and surpassing the Zacks Consensus Estimate by 0.30% [1] - The company's EPS was $0.56, up from $0.48 in the same quarter last year, resulting in an EPS surprise of 9.80% compared to the consensus estimate of $0.51 [1] Financial Performance - Organic Growth was reported at 6%, exceeding the average estimate of 5.2% from three analysts [4] - Organic Growth in Diagnostics and Genomics was 2%, below the two-analyst average estimate of 6.2% [4] - Organic Growth in Protein Sciences was 7%, significantly higher than the average estimate of 2.8% from two analysts [4] - Net Sales from intersegment revenue was -$0.74 million, worse than the average estimate of -$0.55 million, representing a year-over-year decline of 3.7% [4] - Net Sales in Protein Sciences reached $227.69 million, surpassing the average estimate of $224.75 million, with a year-over-year increase of 6.1% [4] - Net Sales in Diagnostics and Genomics were $89.23 million, slightly below the average estimate of $92.50 million, showing a year-over-year growth of 2% [4] Market Performance - Techne's shares have returned -2.2% over the past month, contrasting with the Zacks S&P 500 composite's increase of 10.6% [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]

IAMGOLD (IAG) Q1 2025 Earnings Call May 07, 2025 08:30 AM ET Speaker0 Thank you for standing by. This is the conference operator. Welcome to the IAMGOLD First Quarter twenty twenty five Operating and Financial Results Conference Call and Webcast. As a reminder today, all participants are in listen only mode and the conference is being recorded. After the presentation, there will be an opportunity to ask questions. At this time, I would like to turn the conference over to Graham Jennings, VP, Investor Relati ...

Financial Data and Key Metrics Changes - The company reported organic revenue growth of 10% and total revenue of $413.4 million for the first quarter [11] - Adjusted EBITDA for the first quarter rose 12% to $113.8 million compared to $101.7 million in the prior year period [11] - Adjusted diluted earnings per share grew by 16% [4] - Adjusted free cash flow was $26 million, up 6% from the prior year period [5][13] - GAAP net income for the first quarter was $24.9 million, or GAAP diluted earnings per share of $0.20 [11] Business Line Data and Key Metrics Changes - Insurance Advisory Solutions (IAS) experienced organic revenue growth of 3% [11] - Underwriting Capacity and Technology Solutions (UCTS) saw organic revenue growth accelerate to 32% compared to 21% in the prior year [6][11] - Main Street Insurance Solutions (MIS) delivered total organic revenue growth of 10% [9][11] Market Data and Key Metrics Changes - The IAS business faced a negative impact of 3.5% from rate and exposure changes, compared to a positive 4.5% in the prior year [6] - Client retention improved year over year to approximately 92% [6] - The company noted a more competitive insurance rate environment affecting renewals, particularly in large coastal property [6] Company Strategy and Development Direction - The company aims to vertically integrate across the value chain and bring innovative third-party risk capital solutions to market [8] - The introduction of the Builder Reciprocal Insurance Exchange is expected to support growth in the builder channel [8] - The company remains confident in its ability to maintain double-digit organic revenue growth despite macroeconomic uncertainties [9][15] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the resilience and durability of the business model amid macroeconomic uncertainty [9] - The company anticipates organic revenue growth in the IAS business in the mid to high single-digit range for the year [15] - Management expects adjusted EBITDA between $83 million and $88 million for the second quarter [15] Other Important Information - The company paid $123 million in earn-outs in cash during the first quarter and expects to pay an additional $22 million in the second quarter [5][13] - Net leverage increased slightly to 4.2 times due to significant earn-out payments, but the company aims to bring it below four times by the third quarter [14] Q&A Session Summary Question: Concerns about IAS business performance - Management acknowledged the IAS business was below expectations due to project-based headwinds and a negative impact on renewal premiums, but remains confident in the underlying fundamentals [20][21] Question: Cash flow conversion rate targets - The target for free cash flow conversion rate remains between 50% and 70% over time, with expectations for normalization in subsequent quarters [25][26] Question: Expectations for organic growth acceleration - Management indicated that organic growth is expected to build through the year, particularly in the IAS business, as project-based revenues normalize [53] Question: Market conditions in Florida - Management noted that the Florida insurance market is healthier due to tort reforms, but the cost of risk is expected to grow over time due to increasing building costs and climate event volatility [45] Question: Performance of Juniper Re - Juniper Re is performing well, contributing high single-digit millions in revenue on an LTM basis, with significant strategic value for accessing capacity [57] Question: Impact of wildfires on contingent commissions - There was no significant negative impact from wildfires on contingent commissions, as contracts are tied to non-catastrophe losses [78]

Core Viewpoint - AECOM reported mixed results for Q2 fiscal 2025, with earnings exceeding estimates while revenues fell short of expectations and declined year-over-year, although net service revenues (NSR) increased [1][3]. Financial Performance - Adjusted earnings per share (EPS) reached $1.25, surpassing the consensus estimate of $1.15 by 8.7% and marking a 20% increase from the previous year [3]. - Total revenues amounted to $3.77 billion, a 4% decline year-over-year, while adjusted NSR grew by 4% to $1.87 billion [3]. - Adjusted operating income rose to $218 million, reflecting a 13% year-over-year increase, with an adjusted operating margin of 19.4%, up 130 basis points [6]. Backlog and Pipeline - Total backlog at the end of Q2 was $24.27 billion, an increase from $23.74 billion a year ago, with design backlog reaching a record high [4]. - The book-to-burn ratio in the U.S. design business was 1.2x, marking the 18th consecutive quarter above 1.0, indicating sustained demand [4]. Segment Performance - Revenues in the Americas segment were $2.9 billion, down 5% year-over-year, but NSR increased by 6% to $1.1 billion, driven by strong performance in the design business [5]. - International revenues decreased by 3% to $875 million, while NSR grew by 1% to $742 million, supported by growth in the U.K. and Hong Kong [7]. Cash Flow and Liquidity - Cash and cash equivalents totaled $1.6 billion, slightly up from $1.58 billion at the end of fiscal 2024, with total debt at $2.55 billion [11]. - Operating cash flow increased by 102% year-over-year to $191 million, and adjusted free cash flow rose by 141% to $178 million [11]. Guidance and Outlook - AECOM raised its fiscal 2025 guidance for adjusted EBITDA and EPS, expecting adjusted EPS in the range of $5.10-$5.20, indicating a 14% improvement from fiscal 2024 levels [12][13]. - The company anticipates 5-8% organic NSR growth for fiscal 2025 and expects adjusted EBITDA between $1.180-$1.210 billion, reflecting 9% year-over-year growth at the midpoint [13][14].

Financial Data and Key Metrics Changes - The company reported organic sales growth of 2% in Q1 2025, with adjusted EBITDA increasing by 4% excluding foreign exchange impacts [7][8] - Adjusted EBITDA margins expanded by 20 basis points to 17.5%, despite strong comparisons from the previous year [8] - Adjusted EPS was $0.76, representing a 4% growth when excluding unfavorable foreign exchange impacts [8][15] Business Line Data and Key Metrics Changes - The Color, Additives, and Ink segment saw organic sales growth of 3% and adjusted EBITDA growth of 7%, driven by resilient demand in personal care and food and beverage applications [15][16] - The Specialty Engineered Materials segment's organic sales were flat year-over-year, with adjusted EBITDA declining by 4% due to lower sales in transportation and defense markets [16][17] - The healthcare segment experienced double-digit growth, particularly in medical devices and medical supplies [16] Market Data and Key Metrics Changes - Organic sales in the U.S. and Canada declined by 3%, primarily due to weak demand in consumer and transportation end markets [9] - EMEA region grew by 2%, marking the fourth consecutive quarter of organic growth [9] - Asia reported a 9% increase in organic sales, with growth across most end markets, including transportation [10] - Latin America outpaced market growth with a 17% increase in organic sales, continuing a trend of double-digit growth [10] Company Strategy and Development Direction - The company is focused on cost control and productivity, expecting approximately $30 million in savings from initiatives in 2025 [12] - There is a strategic emphasis on maximizing cash flow and reducing debt, with plans to pay down $100 million to $200 million in debt this year [13][23] - The company aims to prioritize investments in growth vectors, particularly in healthcare and defense, which are expected to outperform the broader market [14][20] Management's Comments on Operating Environment and Future Outlook - Management noted that evolving trade policies have led to uncertainty impacting demand in select markets, particularly in the U.S. [8][20] - The company expects second quarter adjusted EPS of $0.79, representing a 4% growth over the prior year quarter [20] - For the full year, the company models different scenarios, with the low end reflecting flat demand and the high end assuming mid-single-digit growth [22] Other Important Information - The company expects minimal direct impact from tariffs, as most raw materials are sourced and products manufactured locally [19] - The company anticipates 1% to 2% inflation in raw material costs for the full year, with specific trends noted in various materials [84] Q&A Session Summary Question: Defense business outlook after a 5% decline in Q1 - Management expects double-digit growth in the defense business for the first half of the year and high single-digit growth for the full year [27] Question: Transportation market outlook and order books - Transportation is expected to see low negative mid-single-digit growth in the first half, aligning with build rate drops in Europe and the U.S. [28][30] Question: Consumer market weakness in Q1 - The consumer market showed double-digit declines in the U.S. and Canada, with expectations for continued weakness in Q2 [33][34] Question: Share gains in EMEA - Strong performance in healthcare, consumer, and defense markets contributed to share gains in EMEA [35] Question: Packaging segment performance - The packaging segment is driven by strong demand in personal care and beverages, with double-digit growth in personal care applications [39][40] Question: Raw material trends and inflation - The company expects 1% to 2% inflation in raw material costs for the full year, with specific materials trending up or down [84][85]

Financial Data and Key Metrics Changes - In Q1 2025, total sales reached $273.2 million, reflecting a 6% year-over-year increase driven by strong performance in Sealing Technologies and a 9.1% increase in Advanced Surface Technologies (AST) [10][11] - Adjusted EBITDA for the first quarter was $67.8 million, up over 16% compared to the prior year, with an adjusted EBITDA margin of 24.8%, expanding by 210 basis points year-over-year [10][11] - Adjusted diluted earnings per share increased by 21% to $1.9, supported by the factors driving adjusted EBITDA growth [11] Business Line Data and Key Metrics Changes - Sealing Technologies segment sales increased by 4.7% to $179.6 million, with adjusted segment EBITDA rising nearly 11% and a margin of 32.7% [11][13] - Advanced Surface Technologies saw sales increase by over 9% to nearly $94 million, with adjusted segment EBITDA up 18.5% and a margin of 21.9% [14][15] Market Data and Key Metrics Changes - The aerospace, general industrial, and food and pharma markets contributed to the growth in Sealing Technologies, while commercial vehicle OEM demand remained weak [5][11] - In the AST segment, double-digit growth was noted in Precision Cleaning Solutions and Optical Coatings and Filters, despite ongoing volatility in semiconductor capital equipment spending [14][15] Company Strategy and Development Direction - The company is focused on organic growth opportunities where it has technological differentiation and is pursuing acquisitions that meet its strategic and financial criteria [6][8] - The "EnPro 3.0" strategy aims to accelerate profitable growth and enhance market share, particularly in aerospace and adjacent markets [4][21] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to navigate economic uncertainties and maintain strong performance, emphasizing agility and operational excellence [4][8] - The guidance for 2025 remains unchanged, with expectations for low to mid-single-digit sales growth and adjusted EBITDA between $262 million to $277 million [18][19] Other Important Information - The company amended its credit agreement to provide a revolving credit facility of up to $800 million, enhancing financial flexibility for growth initiatives [16][17] - Free cash flow for Q1 was $11.6 million, with capital expenditures expected to be around $50 million for the year [17] Q&A Session Summary Question: Can you provide numbers regarding the minimal impact of tariffs? - Management indicated that most products are produced regionally, with minimal exposure to tariffs, particularly in North America, where Canada and Mexico are exempt [25][27] Question: Are there any end markets showing significant changes compared to 90 days ago? - Management feels equally positive about all markets, with commercial vehicle demand as expected and strong performance in aerospace, food, and pharma [29][31] Question: Any updates on the Arizona facility? - The facility is on track, with early revenue from testing and qualification expected to ramp up throughout the year [41][42] Question: Is there any indication of distributor destocking? - Management has not observed any significant inventory build or destocking, maintaining a balanced supply chain [40] Question: What is the outlook for margin expansion in Sealing Technologies? - Margin expansion is primarily driven by favorable mix and strategic pricing initiatives, with strong demand in aftermarket and aerospace markets [51][53]

Financial Data and Key Metrics Changes - The company reported organic sales growth of 2% in the quarter, with adjusted EBITDA growing by 4% excluding foreign exchange impacts [6][14] - Adjusted EBITDA margins expanded by 20 basis points to 17.5%, despite strong comparisons from the previous year [7] - Adjusted EPS was $0.76, representing a 4% growth when excluding unfavorable foreign exchange impacts [7][14] Business Line Data and Key Metrics Changes - The Color, Additives, and Ink segment saw organic sales growth of 3% and adjusted EBITDA growth of 7% [14] - The Specialty Engineered Materials segment's organic sales were flat year-over-year, with adjusted EBITDA declining by 4% [15] - The healthcare segment experienced double-digit growth, driven by demand in medical devices and supplies [15][16] Market Data and Key Metrics Changes - Organic sales in the U.S. and Canada declined by 3%, primarily due to weak demand in consumer and transportation markets [8] - EMEA region grew by 2%, marking the fourth consecutive quarter of organic growth [8] - Asia's organic sales increased by 9%, with growth across most end markets, particularly transportation [9] - Latin America outpaced market growth with a 17% increase in organic sales, marking the fourth consecutive quarter of double-digit growth [9] Company Strategy and Development Direction - The company is focused on cost control and productivity, expecting approximately $30 million in savings from initiatives in 2025 [11] - There is a strategic emphasis on maximizing cash flow and reducing debt by $100 million to $200 million this year [12][22] - The company aims to prioritize investments in growth vectors, particularly in healthcare and defense, which are expected to outperform the broader market [13][20] Management's Comments on Operating Environment and Future Outlook - Management noted that evolving trade policies have led to uncertainty impacting demand in select markets, particularly in the U.S. [7][19] - For Q2, the company expects adjusted EPS of $0.79, representing a 4% growth over the prior year [20] - The full-year guidance for adjusted EBITDA remains unchanged at $540 million to $570 million, with adjusted EPS guidance of $2.70 to $2.94 [22] Other Important Information - The company expects minimal direct impact from tariffs, as most raw materials are sourced and manufactured locally [12][18] - There is a focus on innovation and reformulation to mitigate tariff impacts and enhance customer offerings [53][54] Q&A Session Summary Question: Defense business expectations for the rest of the year - Management expects double-digit growth in the first half and high single-digit growth for the full year in the defense sector, despite a 5% decline in Q1 [26][27] Question: Transportation market outlook - Transportation is expected to see low negative mid-single-digit growth in the first half, aligning with build rate drops, but a potential recovery in the second half is anticipated [28][29] Question: Consumer market weakness - The consumer market showed double-digit declines in the U.S. and Canada, with expectations for continued weakness in Q2 [32][34] Question: Share gains in EMEA - Strong performance in healthcare, consumer, and defense markets contributed to share gains in EMEA, with notable wins in energy infrastructure [35] Question: Packaging segment performance - The packaging segment is driven by strong demand in personal care and beverages, with double-digit growth in personal care applications [39][40] Question: Raw material trends and inflation - The company expects 1% to 2% inflation for the full year, with specific raw materials showing varied trends [84][85] Question: Cash flow and incentive payouts - The cash flow statement reflects a $53 million use of cash related to incentive accruals, primarily from Q1 payouts [80][81]